C.R. Bard Liable for $2 Million in Federal TVM Case
In an important verdict against transvaginal mesh manufacturer C.R. Bard, a federal jury in West Virginia found the manufacturer liable for $2 million in damages to a woman who suffered serious injuries after being implanted with a product from its Avaulta line of transvaginal mesh. The jury deliberated over 2 days, and finally awarded Donna Cisson $250,000 in compensatory damages and $1.75 million in punitive damages.
This verdict follows last year’s $5.5 million verdict against C.R. Bard as well. That case was the first TVM case to go to trial in the U.S.
In this most recent case against Bard, the jury found that:
- Bard defectively designed the Avaulta implants
- Bard failed to warn doctors and patients about its mesh products’ flaws
- Bard’s mishandling of its transvaginal mesh devices rises to the level of “malice, fraud, or wantonness”
Cisson’s attorneys also showed that Bard knew that it was making the mesh products out of a plastic that should never have been permanently implanted in humans. When it is implanted, it causes serious side effects and in most cases can not ever be removed completely, causing women to suffer ongoing and incurable pain.
If you have received a transvaginal mesh implant and are suffering serious side effects such as erosion, organ perforation, pain during intercourse, and relapse of original symptoms, you may be eligible for compensation. Contact our attorneys today to begin the process of recovery.